Rainbow Childrens Medicare Intrinsic Value
RAINBOW Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹381.84 | ₹305.47 - ₹458.21 | -70.0% | EPS: ₹29.64, Sector P/E: 12x |
| Book Value Method | asset | ₹254.56 | ₹229.10 - ₹280.02 | -80.0% | Book Value/Share: ₹144.61, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹381.84 | ₹343.66 - ₹420.02 | -70.0% | Revenue/Share: ₹177.65, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹509.12 | ₹458.21 - ₹560.03 | -60.0% | EBITDA: ₹628.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹527.35 | ₹421.88 - ₹632.82 | -58.6% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹381.84 | ₹343.66 - ₹420.02 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹381.84 | ₹343.66 - ₹420.02 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹636.40 | ₹572.76 - ₹700.04 | -50.0% | ROE: 20.6%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹381.84 | ₹343.66 - ₹420.02 | -70.0% | EPS: ₹29.64, BVPS: ₹144.61 |
Want to compare with current market value? Check RAINBOW share price latest .
Valuation Comparison Chart
RAINBOW Intrinsic Value Analysis
What is the intrinsic value of RAINBOW?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Rainbow Childrens Medicare (RAINBOW) is ₹381.84 (median value). With the current market price of ₹1272.80, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹254.56 to ₹636.40, indicating ₹254.56 - ₹636.40.
Is RAINBOW undervalued or overvalued?
Based on our multi-method analysis, Rainbow Childrens Medicare (RAINBOW) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.09 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.61 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 20.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 33.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.76x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Rainbow Childrens Medicare
Additional stock information and data for RAINBOW
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹396 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹321 Cr | ₹208 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹327 Cr | ₹95 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹224 Cr | ₹137 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹143 Cr | ₹102 Cr | Positive Free Cash Flow | 8/10 |